As previous studies have identified that the mitogen‐activated protein kinase kinase (MEK)–ERK1/2 pathway regulates MMP9 expression and subsequently controls cancer cell migration and invasion 21, 26, we investigated whether the MEK–ERK1/2 pathway was involved in the role of SIRT6 in OS. The gene discussed is MAPK3; the disease is cancer.